 |
|
|
| |
SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS
|
| |
| |
Reported by Jules Levin
EASL 2013 April 28 Amsterdam
K Rutter1, A Ferlitsch1, A Maieron2, AF Stattermayer1, I Graziadei3, M Dulic4,
M Gschwantler4, R Stauber5, H Hofer1, M Peck-Radosavljevic1, W Vogel3, M Trauner1,
P Ferenci1
1Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria, 2Hospital Elisabethinen Linz, Austria, 3Medical University of Innsbruck, Division of Gastroenterology and Hepatology, Austria, 4Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria, 5Medical University of Graz, Department of Gastroenterology and Hepatology, Austria
|
| |
|
|
|
|
|
